company background image
A001060 logo

JW Pharmaceutical KOSE:A001060 Stock Report

Last Price

₩27.00k

Market Cap

₩670.7b

7D

-9.7%

1Y

-38.5%

Updated

09 Sep, 2024

Data

Company Financials +

JW Pharmaceutical Corporation

KOSE:A001060 Stock Report

Market Cap: ₩670.7b

JW Pharmaceutical Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for JW Pharmaceutical
Historical stock prices
Current Share Price₩27,000.00
52 Week High₩46,568.63
52 Week Low₩24,068.63
Beta0.55
11 Month Change-4.26%
3 Month Change-7.85%
1 Year Change-38.53%
33 Year Change9.63%
5 Year Change11.70%
Change since IPO715.25%

Recent News & Updates

JW Pharmaceutical (KRX:001060) Seems To Use Debt Rather Sparingly

Aug 07
JW Pharmaceutical (KRX:001060) Seems To Use Debt Rather Sparingly

JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality

Mar 21
JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality

Recent updates

JW Pharmaceutical (KRX:001060) Seems To Use Debt Rather Sparingly

Aug 07
JW Pharmaceutical (KRX:001060) Seems To Use Debt Rather Sparingly

JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality

Mar 21
JW Pharmaceutical's (KRX:001060) Earnings Are Of Questionable Quality

Is JW Pharmaceutical Corporation (KRX:001060) An Attractive Dividend Stock?

Apr 08
Is JW Pharmaceutical Corporation (KRX:001060) An Attractive Dividend Stock?

How Many JW Pharmaceutical Corporation (KRX:001060) Shares Do Institutions Own?

Mar 13
How Many JW Pharmaceutical Corporation (KRX:001060) Shares Do Institutions Own?

Is JW Pharmaceutical (KRX:001060) Using Too Much Debt?

Feb 15
Is JW Pharmaceutical (KRX:001060) Using Too Much Debt?

JW Pharmaceutical's(KRX:001060) Share Price Is Down 24% Over The Past Three Years.

Jan 19
JW Pharmaceutical's(KRX:001060) Share Price Is Down 24% Over The Past Three Years.

Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend

Dec 24
Do These 3 Checks Before Buying JW Pharmaceutical Corporation (KRX:001060) For Its Upcoming Dividend

Would JW Pharmaceutical Corporation (KRX:001060) Be Valuable To Income Investors?

Nov 30
Would JW Pharmaceutical Corporation (KRX:001060) Be Valuable To Income Investors?

Shareholder Returns

A001060KR PharmaceuticalsKR Market
7D-9.7%-9.1%-5.4%
1Y-38.5%8.5%-3.8%

Return vs Industry: A001060 underperformed the KR Pharmaceuticals industry which returned 8.5% over the past year.

Return vs Market: A001060 underperformed the KR Market which returned -3.8% over the past year.

Price Volatility

Is A001060's price volatile compared to industry and market?
A001060 volatility
A001060 Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement6.6%
10% most volatile stocks in KR Market11.9%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A001060's share price has been volatile over the past 3 months.

Volatility Over Time: A001060's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19451,064Young-Sub Shinwww.jw-pharma.co.kr

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment.

JW Pharmaceutical Corporation Fundamentals Summary

How do JW Pharmaceutical's earnings and revenue compare to its market cap?
A001060 fundamental statistics
Market cap₩670.65b
Earnings (TTM)₩35.23b
Revenue (TTM)₩742.09b

18.8x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A001060 income statement (TTM)
Revenue₩742.09b
Cost of Revenue₩411.74b
Gross Profit₩330.35b
Other Expenses₩295.12b
Earnings₩35.23b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.43k
Gross Margin44.52%
Net Profit Margin4.75%
Debt/Equity Ratio43.5%

How did A001060 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

26%

Payout Ratio